Xvivo Perfusion AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	812.17	822.42	597.54	415.29	258.39
Revenue Growth (YoY)	-1.25%	37.63%	43.89%	60.72%	43.66%
Cost of Revenue	212.67	206	152.43	118.34	70.11
Gross Profit	599.49	616.42	445.11	296.96	188.28
Selling, General & Admin	376.61	378.9	309.21	223.38	153.38
Research & Development	130.17	147.77	135.94	69.34	54.04
Other Operating Expenses	-1.7	-1.09	-5.43	-0.22	-0.39
Operating Expenses	505.07	525.58	439.72	292.5	207.02
Operating Income	94.42	90.84	5.4	4.45	-18.74
Interest Expense	-3.48	-1.26	-1.19	-0.61	-0.28
Interest & Investment Income	7.88	17.16	8.85	2.12	-
Currency Exchange Gain (Loss)	-69.96	32.39	9.69	17.09	5.98
Other Non Operating Income (Expenses)	12.39	63.04	72.78	-0.49	19.75
EBT Excluding Unusual Items	41.25	202.16	95.52	22.58	6.71
Merger & Restructuring Charges	-2.3	-1.43	-	-	-
Gain (Loss) on Sale of Assets	-0.39	-0.78	-1	-0.26	-0.04
Pretax Income	38.56	199.95	94.52	22.31	6.67
Income Tax Expense	13.4	27.77	2.7	3.89	-1.49
Net Income	25.16	172.18	91.82	18.43	8.15
Net Income to Common	25.16	172.18	91.82	18.43	8.15
Net Income Growth	-85.39%	87.52%	398.29%	126.04%	-
Shares Outstanding (Basic)	31	31	30	30	29
Shares Outstanding (Diluted)	32	32	30	30	29
Shares Change (YoY)	-0.29%	5.73%	1.39%	2.04%	6.49%
EPS (Basic)	0.80	5.47	3.07	0.62	0.28
EPS (Diluted)	0.80	5.44	3.07	0.62	0.28
EPS Growth	-85.31%	77.35%	394.72%	121.43%	-
Free Cash Flow	7.35	40.56	3.27	9.67	-22.25
Free Cash Flow Per Share	0.23	1.28	0.11	0.33	-0.77
Gross Margin	73.81%	74.95%	74.49%	71.50%	72.87%
Operating Margin	11.63%	11.04%	0.90%	1.07%	-7.25%
Profit Margin	3.10%	20.94%	15.37%	4.44%	3.16%
Free Cash Flow Margin	0.90%	4.93%	0.55%	2.33%	-8.61%
EBITDA	129.31	118.43	19.03	13.3	-11.7
EBITDA Margin	15.92%	14.40%	3.19%	3.20%	-4.53%
D&A For EBITDA	34.9	27.59	13.64	8.85	7.04
EBIT	94.42	90.84	5.4	4.45	-18.74
EBIT Margin	11.63%	11.04%	0.90%	1.07%	-7.25%
Effective Tax Rate	34.74%	13.89%	2.86%	17.42%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.